Funds raised this year will be going to the Brain Tumour Alliance Australia in honour of a NAPSA member recently diagnosed with glioblastoma
NAPSA’s Charity Cup will this year be supporting the Brain Tumour Alliance Australia (BTAA), a national support organisation for brain tumour patients, carers and families.
It was established in 2008 by a group of people who had been affected by a brain tumour – either they had a family member with one, had lost a family member to one or they were a patient themselves.
The NAPSA Charity Cup is running from 1 April to 31 May 2019, with funds primarily going towards funding BTAA’s e-news platform where the latest information on brain tumour treatment, updates in brain tumour advocacy, and patient lifestyle and support advice are presented.
“This year NAPSA is raising awareness for the Brain Tumour Alliance Australia, a charity that hits close to home for many NAPSA members as one of our own, Alycia Eaton, was recently diagnosed with glioblastoma,” says Jess Hsaio, NAPSA President.
“The BTAA provides support to not only to people living with a brain tumour, but to their family, friends and caregivers. Alycia is a very close friend of mine and she has been a fighter having experienced cancer a couple of times in her life.”
“I am very excited about this year’s campaign,” says Antoni Ukalović, NAPSA Pharmacy Awareness Chair.
“I have been in contact with each branch representative over the last couple of months in preparation for the campaign. I’ve seen what some branches have got organised over the next two months and I really look forward to seeing how they go,” Mr Ukalović tells AJP.
“It’s a great charity we are raising funds for this year with the money primarily going to fund BTAA’s e-news platform, which is vital in keeping patients up to date. As health professionals we all know how valuable patient education on their medical conditions, and lifestyle advice and support, can be.”
“BTAA is very excited that NAPSA has chosen our organisation for their Charity Cup activities in April and May 2019,” says charity director Catherine Hindson.
“The funds will be thankfully received as we rely on donations and we are so pleased to have the opportunity to speak to pharmacy students about brain tumours and the on-the-ground support that BTAA provides to patients.
“The survival statistics on malignant brain tumours are poor. There are approximately 1,800 people diagnosed each year and about 1,400 die each year,” explains Ms Hindson.
“It is the leading cause of cancer-related deaths in children under age 15 and the second leading cause of cancer-related deaths in individuals aged 15-39.
“There are approximately 2,000 people diagnosed with benign brain tumours. These patients can have a life time of debilitating issues, e.g. seizures, cognitive impairment and physical disabilities.”